entertainment
A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?
See below for an archived chat with Helen Branswell about these issues and more.
advertisement
Previous article：
How the BIOSECURE Act is already affecting U.S., Chinese life science firms
Next article： Drug repurposing or repositioning? The language matters
Next article： Drug repurposing or repositioning? The language matters
